Tempest Therapeutics Inc. sell Lokrim
Start price
04.08.24
/
20%
€1.40
Target price
04.08.25
-
Performance (%)
-17.74%
Price
09.09.24
€1.16
Summary
This prediction is currently active. The prediction for Tempest Therapeutics Inc. shows a convincing performance of -17.74%. This prediction currently runs until 04.08.25. The prediction end date can be changed by Lokrim at any time. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Tempest Therapeutics Inc. | -0.858% | -0.858% |
| iShares Core DAX® | -2.385% | 3.986% |
| iShares Nasdaq 100 | -4.527% | -0.258% |
| iShares Nikkei 225® | -4.129% | 4.382% |
| iShares S&P 500 | -2.885% | 1.387% |
According to Lokrim what are the pros and cons of Tempest Therapeutics Inc. for the foreseeable future?
Pros
Cons
Risky Investment
Little known brand
Comments by Lokrim for this prediction
In the thread Tempest Therapeutics Inc. diskutieren
Sell Tempest Therapeutics Inc.
Stopped prediction by Lokrim for Tempest Therapeutics Inc.
Tempest Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.22
23.08.21
23.08.21
-
23.08.22
23.08.22
-78.40%
24.08.22
24.08.22
Risky Investment
